Invacare (IVC) PT Raised to $21.00
Invacare (NYSE:IVC) had its target price hoisted by KeyCorp from $20.00 to $21.00 in a research note issued to investors on Friday morning. They currently have an overweight rating on the health services provider’s stock. KeyCorp also issued estimates for Invacare’s Q1 2018 earnings at ($0.48) EPS, Q2 2018 earnings at ($0.34) EPS, Q3 2018 earnings at ($0.17) EPS, Q4 2018 earnings at ($0.16) EPS and FY2019 earnings at ($0.24) EPS.
Other equities analysts have also issued reports about the stock. ValuEngine raised shares of Invacare from a sell rating to a hold rating in a report on Sunday, December 31st. Zacks Investment Research raised shares of Invacare from a sell rating to a hold rating in a report on Wednesday, January 31st. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company’s stock. Invacare currently has a consensus rating of Hold and a consensus target price of $16.50.
Invacare (NYSE:IVC) opened at $18.50 on Friday. The company has a current ratio of 2.10, a quick ratio of 1.54 and a debt-to-equity ratio of 0.57. Invacare has a 1-year low of $10.20 and a 1-year high of $19.05.
The company also recently announced a quarterly dividend, which was paid on Tuesday, January 16th. Stockholders of record on Thursday, January 4th were issued a dividend of $0.0125 per share. This represents a $0.05 annualized dividend and a dividend yield of 0.27%. The ex-dividend date of this dividend was Wednesday, January 3rd. Invacare’s dividend payout ratio (DPR) is -2.13%.
Several large investors have recently bought and sold shares of the company. Barrow Hanley Mewhinney & Strauss LLC grew its stake in Invacare by 654.1% in the 3rd quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 2,383,222 shares of the health services provider’s stock valued at $37,535,000 after acquiring an additional 2,067,186 shares during the period. Northpointe Capital LLC grew its stake in Invacare by 96.8% in the 3rd quarter. Northpointe Capital LLC now owns 1,151,700 shares of the health services provider’s stock valued at $18,139,000 after acquiring an additional 566,574 shares during the period. Goldman Sachs Group Inc. grew its stake in Invacare by 326.4% in the 2nd quarter. Goldman Sachs Group Inc. now owns 723,650 shares of the health services provider’s stock valued at $9,552,000 after acquiring an additional 553,954 shares during the period. Keeley Teton Advisors LLC grew its stake in Invacare by 1,779.1% in the 3rd quarter. Keeley Teton Advisors LLC now owns 442,715 shares of the health services provider’s stock valued at $6,973,000 after acquiring an additional 419,155 shares during the period. Finally, Koch Industries Inc. acquired a new stake in Invacare in the 2nd quarter valued at $255,000.
ILLEGAL ACTIVITY NOTICE: This piece was first published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://theolympiareport.com/2018/02/12/invacare-ivc-pt-raised-to-21-00.html.
Invacare Company Profile
Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.
Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.